Delivery Order 75N95018D00023-75N95021F00001

Award Date 4/5/21
Potential Completion Date 3/13/22
Potential Value $2.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Brunswick, NJ 08901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Rutgers, The State University has been awarded a task order against an existing National Institute on Drug Abuse (NIDA) indefinite delivery contract to establish and operate the NIDA Center for Genetic Studies. The task order, valued at $2,716,366, provides continued genetic research services for the Center between March 2023 and March 2024. Specifically, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants...
The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
This is a $1,647,593 firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University of New Jersey. The award is for the NIDA Center for Genetic Studies, where Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023 to March 2028. This delivery order provides $1.6 million...
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...
This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
This is a firm-fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), an agency within the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract, valued at $1,982,526.92, is for the NIDA Adolescent Brain Cognitive Development (ABCD) Study Genome Center and Biospecimens Repository. Rutgers, through its Research Financial Services Division, will receive, process, store, and distribute de-identified clinical data and...
This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
This is a $79,442.40 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Rutgers, The State University. The contract is for the creation of induced pluripotent stem cells, which are a type of stem cell that can be derived from adult cells. The contract does not have a set-aside designation. Rutgers, a major public research institution, has a long history of receiving federal...
This is a $16,252,811.88 definitive contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Rutgers, The State University for biomedical research and development services. The contract has a firm fixed price pricing type and a period of performance through July 13, 2013. Rutgers, a major public research institution, will provide applied and exploratory biomedical research under this contract, which supports the NIDDK Genetics Repository program. This...
  • 75N95018D00023
    Indefinite Delivery Contract
  • 75N95018D00023-75N95021F00001
    Delivery Order

Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. As the prime contractor, Rutgers will leverage its expertise and resources to further NIDA's understanding of genetics and its role in substance use disorders.

Generated 12/24/23, 11:50 PM